Probiotics can support the effects of antidepressants to help relieve symptoms of depression.
Polyphenols can reduce inflammation in older people by altering the intestinal microbiota and inducing the production of indole 3-propionic acid.
Researchers say the gut microbiome may be a viable targetable biomarker to improve immunotherapy responses in those with glioblastoma and a range of other cancers.
A newly invented soft, implantable probe can interface between gut and brain tissue, measuring both dopamine and serotonin levels. The device has applications for depression, Parkinson's disease, and intestinal disorders.
Microbes in the gut influence what an animal chooses to eat. Altering the microbiome resulted in changes to preferred diets.
Hypothalamic neurons directly detect variations in bacterial activity and adapt appetite and body temperature accordingly. The findings demonstrate a direct dialog occurs between the brain and the gut microbiota.
A new study aims to investigate the role the gastrointestinal microbiota may play in Alzheimer's disease and other neurodegenerative disorders.
Study reveals an association between intestinal inflammation and the gut microbiome in the development and progression of ALS.
Modulating the gut's microbiome by fecal implants induced behavioral and cognitive changes in mouse models of Alzheimer's disease. Researchers say the findings could help develop therapies to stall dementia via probiotic use and fecal transplantation.
Researchers have identified a link between multiple sclerosis and a decreased level of specific gut bacteria. Additionally, the study reveals those who consume more meat may be at increased risk of developing the autoimmune disorder.
A new study has uncovered a link between gut bacteria and chronic inflammatory diseases like arthritis.
Microglia, a key immune cell in the brain, appears to mediate the relationship between the gut microbiome and amyloid-beta deposits in male mouse models of Alzheimer's disease.
